CN107245109A - A kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2 and preparation method thereof - Google Patents
A kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2 and preparation method thereof Download PDFInfo
- Publication number
- CN107245109A CN107245109A CN201710676689.3A CN201710676689A CN107245109A CN 107245109 A CN107245109 A CN 107245109A CN 201710676689 A CN201710676689 A CN 201710676689A CN 107245109 A CN107245109 A CN 107245109A
- Authority
- CN
- China
- Prior art keywords
- sheep
- fusion protein
- interferon
- leu
- ifn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2 and preparation method thereof; the fusion protein is formed by sheep albumin, sheep interferon gamma and sheep interleukin 2 through flexible linker connections, and fusion protein through being freeze-dried to obtain after freeze drying protectant mixture with recombinating sheep long-acting interferon.The restructuring sheep long-acting interferon is remarkably improved the half-life period of sheep interferon, and the half-life period of more common sheep interferon improves more than 17 times, and with broad-spectrum disease resistance toxic action and can improve the immune response of sheep itself.
Description
Technical field
The invention belongs to technical field of biological genetic engineering, and in particular to thin in vain by sheep albumin, sheep interferon gamma and sheep
Fusion protein that born of the same parents' interleukin 2 is constituted and preparation method thereof.
Background technology
The animal infectious disease as caused by virus seriously constrains the sound development of every country and regional aquaculture, in
State is the most country of sheep breeding stock, the amount of delivering for sale, Mutton yield in the world, and Mutton Sheep Industry is also the mainstay of China's animal husbandry
One of industry.With the sustainable development of sheep aquaculture, the problem of inevitably facing disease caused by virus, domestic animals disease
Huge economic loss is not only caused to sheep culturist, more seriously, some Zoonosis communicable diseases return the mankind
Health care belt carrys out potential threat.
The preventing and treating of current sheep class communicable disease mainly uses vaccine immunity and drug therapy, due to the serum of vaccine immunity
Type is single, and the serotype of virus is complicated, and strain variation is fast, often results in vaccine immunity failure.Some virosis there is no epidemic disease at present
Seedling can use, and some viruses may also directly jeopardize the health of the mankind.
Conventional drug therapy is mainly treated using antibiotic, but extensive and a large amount of due to antibiotic in recent years
Use, cause endurance strain largely to produce, and given people by food chain infection, bigger threat is carried out to mankind's health care belt.It is existing
In some countries, oneself prohibites the application of some antibiotic and antiseptic in aquaculture.Therefore, using interferon actively
It will be the problem of mankind pay close attention to the most to treat and prevent domestic animal, the viral disease of poultry.
IFN is that the infection induced body of a viroid is produced with broad-spectrum antiviral, antitumor and with immunoregulation effect
Protein, nineteen fifty-seven, Issacs and Lindeman had found first, and it is the multi-functional cell factor of a class, with cell receptor knot
After conjunction, it can induce body and produce many species-specific proteins and enzyme, mainly by suppressing viral gene transcription and degraded virus
RNA suppresses the growth and breeding of virus and plays the activity of antitumor grade.It is existing, it is known that γ types IFN be T cell by activating and
NK cells are produced, with relatively strong antiviral and immunoloregulation function.Numerous studies show that interferon gamma is except with broad-spectrum disease resistance
Outside malicious function, the adjustment effect of key is also played to immune system, so IFN-γ is also known as immunological regulation interferon.Although each
The interferon of type can mediated cell to virus infection reaction, but interferon gamma immunoregulatory activity coordinate exempt from
Epidemic disease is reacted and determines to play even more important effect in the long-term antiviral state of body, thus interferon gamma have it is particularly important
Clinical value.
Cell factor IL-2 is interleukin 2, also known as SCIF.The main T lymphocytes by activating are produced
The cell factor with extensive bioactivity, can both promote lymphopoiesis, strengthen immunologic function, but can restricted T it is thin
Born of the same parents react and strengthen the immune tolerance of body, therefore available for treatment tumour, infectious diseases and autoimmune disease.In animal doctor
In, because IL-2 can improve the immune response of vaccine and reduce the generation of disease, also there is wide application prospect.IL-2 is because of energy
Strengthen the immune level of body, improve the resistance against diseases of body, thus exempt from for bacillary, viral and parasitic diseases
Epidemic disease is treated.In addition, IL-2 can also influence the metabolism of medicine, make the metabolism time lengthening of medicine, action time increase, so as to improve
Curative effect of medication.IL-2, according to gene constructed, constitutes fusion protein with other cell factors, is produced and is carried with the antibody for strengthening vaccine
High cellular immune level.
Seralbumin is the important component of blood plasma, is difficult to pass through glomerulus under normal circumstances, internal distributed pole it is wide and
There is no zymetology and immunologic competence, be preferable pharmaceutical carrier.Albumin fusion technology has the advantage that:Albumin and target egg
Linked in the cell through protein translation system by peptide bond in vain, be not required to extra extracorporeal treatment;The expression of albumin is higher,
The expression of destination protein can be improved after being merged with it;Albumin is one stable " inert protein ", after being merged with it
The stability of destination protein can be improved;Albumin fusion protein has longer drug half-life, by small molecular protein medicine
It can be expected to improve half-life period in blood with Albumin fusion.At present, in experimental animal after multiple protein and Albumin fusion
The extension of Half-life in vivo is confirmed.
The limitation of natural interferon and the current generally existing half-life short of artificial recombination interferon, half-life period is generally 2-4
Individual hour.Half-life short brings great inconvenience, the increase for the treatment of number of times, corresponding time cost and financial cost to treatment
Increase therewith, and the tenability limit of body is also possible to be broken the generation for causing adverse reaction.The main cause of half-life short
There are two:The too small tachytrophism in vivo of molecular weight of interferon, interferon especially recombinant interferon affinity is poor to be exempted from
Epidemic disease system is removed.And common long-acting interferon is using polyethylene glycol fused interferon as representative on the market, the layer only in molecular weight
Partly solved on face interferon molecule amount it is small and the problem of cause half-life short.
And common long-acting interferon is using polyethylene glycol fused interferon as representative on the market, only in the aspect of molecular weight
Part solve interferon molecule amount it is small and the problem of cause half-life short, while polyethylene glycol fused interferon cost is very
Height, is unfavorable for clinically applying.
The content of the invention
In order to solve the above technical problems, being situated between the invention provides one kind by sheep albumin, sheep interferon gamma and sheep leucocyte
Fusion proteins and preparation method thereof of the composition of element 2, and thus fusion protein with after freeze drying protectant mixture, freeze-dried system
Standby to obtain a kind of restructuring sheep long-acting interferon, the restructuring sheep long-acting interferon is remarkably improved the half-life period of sheep interferon, compared with
The half-life period of common sheep interferon improves more than 17 times, and with broad-spectrum disease resistance toxic action and can improve the immune of sheep itself and answer
Answer.
The technical scheme that the present invention takes is:
A kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2, the fusion protein
Amino acid sequence table is as shown in the > of 400 < of SEQUENCE LISTING 1.
Present invention also offers the gene for encoding above-mentioned fusion protein, the nucleotides sequence list such as SEQUENCE of the gene
Shown in the > of 400 < of LISTING 2, genome 1 is designated as;Or as shown in the > of SEQUENCE LISTING400 < 3, it is designated as genome 2.
Fusion protein described in the equal codified of the genome 1 and the genome 2.Genome 2 is the nucleosides to genome 1
Acid sequence optimize after result, be considered as the gene during usual codon adaptation indexI CAI=1.0 in the expression system
In be optimal high efficient expression state, CAI values are lower to show that expression is lower in host.Most preferable point of G/C content in gene
Cloth scope is 30~70%, and the scope is exceeded in any region can influence translation and transcriptional efficiency.Sent out using software detection
Now the codon of sheep albumin, sheep IFN-γ, sheep IL-2 original genes codon adaptation indexI (CAI) in Escherichia coli is distinguished
It is 44.0%, 40.9%, 54.0% for 0.23,0.25,0.27, GC percentages;And by sheep albumin, sheep IFN-γ, sheep
Obtained after IL-2 gene optimizations each gene in Escherichia coli codon adaptation indexI (CAI) be 0.99,1.0,1.0, GC percentages
Than 50.1%, 44.1%, 53.0%.Significantly reduce the utilization rate of low codon by gene optimization, it is to avoid rare codon
Influence of the son to protein expression, improves the G/C content of gene, improves transcription and translation efficiency.
Present invention also offers the expression vector containing genome 1 or genome 2.
Further, the expression vector is the pET-32a coli expression carriers containing genome 1 or genome 2.
Present invention also offers the genetic engineering bacterium containing genome 1 or genome 2.
Further, the genetic engineering bacterium is pET-32a/rAlb-IFN γ-IL2.
Host cell containing genome 1 or genome 2 falls within protection scope of the present invention, further, the place
Chief cell is e. coli host cell, further, and the e. coli host cell is BL21 (DE3) competent cell
Or BL21 (DE3) competent cell with pGro7 plasmids.
Sheep long-acting interferon is recombinated present invention also offers one kind, the restructuring sheep long-acting interferon is by described fusion egg
In vain with after freeze drying protectant mixture, it is freeze-dried to form.
The freeze drying protectant is glycerine, mannitol and sucrose, is buffer solution, the final concentration of three with 10mmol/L PBS
For glycerine 100mL/L, mannitol 0.12g/mL and sucrose 0.025g/mL.
The invention also discloses the preparation method of the fusion protein, the preparation method comprises the following steps:It will contain
The expression vector of genome 1 or genome 2 is imported into e. coli host cell, obtains genetic engineering bacterium, genetic engineering bacterium
The crude product of the fusion protein is obtained after IPTG induced expressions, it is purified to can obtain fusion protein afterwards.
The expression vector is the pET-32a coli expression carriers containing genome 1 or genome 2;
The genetic engineering bacterium is pET-32a/rAlb-IFN γ-IL2, and its preparation method is:
(1) primer is designed, the white egg of sheep for connecting flexible linker sequences is obtained or be manually respectively synthesized by reverse transcription
In vain, sheep interferon gamma, the target gene of sheep interleukin 2;By flexible linker by sheep albumin, sheep interferon gamma, sheep
The target gene of interleukin 2 is connected, the nucleotides sequence list such as SEQUENCE of the target gene after connection
Shown in the > of 400 < of LISTING 2 or as shown in the > of 400 < of SEQUENCE LISTING 3;
(2) target gene after connection is connected on pET-32a plasmids and obtains expression vector;
(3) expression vector is imported into e. coli host cell, you can obtain genetic engineering bacterium pET-32a/rAlb-
IFNγ-IL2。
The e. coli host cell is BL21 (DE3) competent cells or BL21 (DE3) senses with pGro7 plasmids
By state cell.
The method of the purifying is:Through affinity chromatography, anion-exchange chromatography and molecular sieve after the crude product elder generation of fusion protein
Chromatographic purifying.
Described BL21 (DE3) competent cell with pGro7 plasmids is purchased from Shanghai Jinan Technology Co., Ltd./glad hundred promise
Biology, article No. is V205.
The acquisition methods of the genome 1 are:
A. design of primers
The primer sequence of sheep albumin (Alb) is:
Upstream Alb-F1:CCGGAATTCATGAAGTGGGTGACT, with EcoRI restriction enzyme sites;
Downstream Alb-R1:
ACCACCACCAGAACCACCACCACCGGCTAAGGCTGCTT, with flexible linker;
The primer sequence of sheep interferon gamma (IFN-γ) is:
Upstream IFN-γ-F1:
GGTGGTTCTGGTGGTGGTGGTTCTATGAAATACACAAGCTC, with flexible linker;
Downstream IFN-γ-R1:
ACCACCACCAGAACCACCACCACCCATTGATGCTCTCCG, with flexible linker;
The primer sequence of sheep interleukin 2 (IL-2) is:
Upstream IL-2-F1:
GGTGGTTCTGGTGGTGGTGGTTCTATGTACAAGATACAACCC, with flexible linker;
Downstream IL-2-R1:CCCTCGAGAGTCATTGTTGAGTAGAT, with XhoI restriction enzyme sites;
B. RNA is extracted from sheep liver, sheep Alb, sheep IFN-γ and sheep IL-2 target gene, three are obtained by reverse transcription
The gene order of person respectively as shown in the > of 400 < of SEQUENCE LISTING 400 <, 4 >, SEQUENCE LISTING 5 and
Shown in the > of 400 < of SEQUENCE LISTING 6;
Respectively using sheep Alb, sheep IFN-γ and sheep IL-2 target gene as template, and it is utilized respectively sheep Alb, sheep IFN-γ
Enter performing PCR amplification with sheep IL-2 upstream and downstream primer.
PCR reaction systems and condition are:In 25 μ L overall reaction system, the μ L of template ribonucleic acid 1.5, upstream and downstream primer each 0.5
μ L, reverse transcriptase 2.5 μ L, dNTP Mix are 10 μ L, plus RNase Free water is to 25 μ L;The reaction condition of the RT-PCR reactions
For:50 DEG C of reverse transcriptions 30min, 95 DEG C of pre-degeneration 4min, into circulation;95 DEG C of denaturation 45s, 58 DEG C of annealing 45s, 72 DEG C of extensions
1kb/min, is circulated 35 times, last 72 DEG C of extensions 10min.
C. rAlb-IFN γ genes are obtained using flexible linker connection sheep Alb and sheep IFN-γ target gene
The PCR reaction systems and reaction condition of connection be:In 25 μ L overall reaction system, connect flexible linker's
The μ L of Alb gene templates DNA 1, connect flexible linker 1 μ L, Alb sense primer of IFN-γ template DNA 0.5 μ L, IFN-
0.5 μ L, Taq archaeal dna polymerase of γ anti-sense primers 2.5 μ L, dNTP Mix is 10 μ L, plus RNase Free water is to 25 μ L;Connection
PCR reaction conditions are:95 DEG C of pre-degeneration 4min, into circulation:94 DEG C of denaturation 45s;58 DEG C of annealing 45s, 72 DEG C of extension 1kb/
Min, totally 35 circulations;Last 72 DEG C of extensions 10min.
D. rAlb-IFN γ-IL2 are obtained using flexible linker connections rAlb-IFN γ genes and sheep IL-2 target gene
Gene
The PCR reaction systems and reaction condition of connection be:In 25 μ L overall reaction system, rAlb-IFN γ gene templates
The μ L of DNA 1, connect the flexible linker μ L of 1 μ L, Alb sense primer of IL-2 template DNAs, 0.5 μ L, IL-2 anti-sense primer 0.5,
Taq archaeal dna polymerases 2.5 μ L, dNTP Mix is 10 μ L, plus RNase Free water is to 25 μ L;Connecting PCR reaction conditions is:95℃
Pre-degeneration 4min, into circulation:94 DEG C of denaturation 45s;58 DEG C of annealing 45s, 72 DEG C of extension 1kb/min, totally 35 circulations;Last 72
DEG C extension 10min.
Genome 2 is artificial synthesized gene after being optimized to genome 1, the acquisition methods of the genome 2
For:
A. design of primers
The primer sequence of sheep albumin (Alb) is:
Upstream Alb-F2:CCGGAATTCATGAAATGGGTTACCTT, with EcoRI restriction enzyme sites;
Downstream Alb-R2:
ACCACCACCAGAACCACCACCACCAGCCAGAGCAGCC, with flexible linker;
The primer sequence of sheep interferon gamma (IFN-γ) is:
Upstream IFN-γ-F2:
GGTGGTTCTGGTGGTGGTGGTTCTATGAAATACACCTCTTCT, with flexible linker;
Downstream IFN-γ-R2:
ACCACCACCAGAACCACCACCACCCATAGAAGCACGACG, with flexible linker;
Sheep interleukin 2 (IL-2):
Upstream IL-2-F2:
GGTGGTTCTGGTGGTGGTGGTTCTATGTACAAAATCCAGCC, with flexible linker;
Downstream IL-2-R2:
CCCTCGAGGGTCATGGTAGAGTAGA, with XhoI restriction enzyme sites.
B. the sheep Alb, sheep IFN-γ and sheep IL-2 target gene, the gene order of three is respectively such as SEQUENCE
Shown in the > of 400 < of LISTING 400 <, 7 >, SEQUENCE LISTING, 400 <, 8 > and SEQUENCE LISTING 9;
Respectively using sheep Alb, sheep IFN-γ and sheep IL-2 target gene as template, and it is utilized respectively sheep Alb, sheep IFN-γ
Enter performing PCR amplification with sheep IL-2 upstream and downstream primer.
PCR reaction systems and condition are:In 25 μ L overall reaction system, the μ L of genomic DNA 1, upstream and downstream primer is each
0.5 μ L, reverse transcriptase 2.5 μ L, Taq archaeal dna polymerase is 10 μ L, plus RNase Free water is to 25 μ L;The RT-PCR reactions
Reaction condition is:95 DEG C of pre-degeneration 4min, into circulation;95 DEG C of denaturation 45s, 60 DEG C of annealing 45s, 72 DEG C of extension 1kb/min, are followed
Ring 35 times, last 72 DEG C of extensions 10min.
C. flexibility linker connection sheep Alb and sheep IFN-γ target gene rAlb-IFN γ genes are utilized
The PCR reaction systems and reaction condition of connection be:In 25 μ L overall reaction system, connect flexible linker's
The μ L of Alb gene templates DNA 1, connect flexible linker 1 μ L, Alb sense primer of IFN-γ template DNA 0.5 μ L, IFN-
0.5 μ L, Taq archaeal dna polymerase of γ anti-sense primers 2.5 μ L, dNTP Mix is 10 μ L, plus RNase Free water is to 25 μ L;Connection
PCR reaction conditions are:95 DEG C of pre-degeneration 4min, into circulation:94 DEG C of denaturation 45s;60 DEG C of annealing 45s, 72 DEG C of extension 1kb/
Min, totally 35 circulations;Last 72 DEG C of extensions 10min.
D. rAlb-IFN γ-IL2 are obtained using flexible linker connections rAlb-IFN γ genes and sheep IL-2 target gene
Gene
The PCR reaction systems and reaction condition of connection be:In 25 μ L overall reaction system, rAlb-IFN γ gene templates
The μ L of DNA 1, connect the flexible linker μ L of 1 μ L, Alb sense primer of IL-2 template DNAs, 0.5 μ L, IL-2 anti-sense primer 0.5,
Taq archaeal dna polymerases 2.5 μ L, dNTP Mix is 10 μ L, plus RNase Free water is to 25 μ L;Connecting PCR reaction conditions is:95℃
Pre-degeneration 4min, into circulation:94 DEG C of denaturation 45s;60 DEG C of annealing 45s, 72 DEG C of extension 1kb/min, totally 35 circulations;Last 72
DEG C extension 10min.
Present invention also offers the application of the restructuring sheep long-acting interferon, its long half time had up to more than 70 hours
Broad-spectrum disease resistance toxic action and the immune response that sheep itself can be improved.
Compared with prior art, the present invention has the advantages that:
1. sheep Alb, sheep IFN-γ and sheep IL-2 genes are realized into amalgamation and expression by flexible linker, interferon is improved
Half-life period, compared with plain interferon, improve more than 17 times;
2. by being optimized to sheep Alb, sheep IFN-γ and sheep IL-2 genes, improve sheep Alb, sheep IFN-γ and sheep
The expression quantity of IL-2 fusion proteins.
3. using recombination bacillus coli pET-32a/rAlb-IFN γ-IL2 as expression bacterial strain, by introducing molecular chaperones
PGro7 plasmids, it is less to produce inclusion body in protein expression, forms great amount of soluble albumen, it is to avoid inclusion body denaturation and multiple
The process of property, substantially reduces the time of expressing fusion protein;
4. the fusion protein disclosed by the invention being made up of sheep Alb, sheep IFN-γ and sheep IL-2 not only has IFN-γ
Broad-spectrum disease resistance toxic action, while significantly improving the immune response of sheep itself.
Brief description of the drawings
Fig. 1 is that sheep albumin gene, sheep interleukin-22 gene and sheep Interferon-gamma gene RT-PCR in embodiment 1 are expanded
Result;Swimming lane M:DNA Marker DL2000;Swimming lane 1:Sheep interleukin-22 gene RT-PCR amplified productions;Swimming lane 2:Sheep disturbs
Plain γ genes RT-PCR amplified productions;Swimming lane 3:Sheep albumin gene RT-PCR amplified productions;
The knot that Fig. 2 expands for the PCR after the sheep Alb in embodiment 1, sheep IFN-γ and sheep IL-2 target gene connection
Really;Swimming lane M:DNA Marker DL10000;Swimming lane 1:Sheep albumin gene, sheep Interferon-gamma gene and sheep interleukin-22 gene
Ligation amplification product;
PCR amplifications and double digestion qualification result of the Fig. 3 for the positive colony plasmid in embodiment 1;Swimming lane M:DNA
Marker DL10000;Swimming lane 1:Plasmid PCR result;Swimming lane 2:Recombinant plasmid double digestion result;
Fig. 4 be embodiment 1 in recombinant protein SDS-PAGE electrophoretic examinations results;Swimming lane M:Albumen Marker;Swimming lane
1:Supernatant after bacterial cell disruption after recombinant bacterium induction;Swimming lane 2:Precipitated after bacterial cell disruption after recombinant bacterium induction;Swimming lane 3:It is unloaded
Control;
Fig. 5 is the Western Blot qualification results for the fusion protein that embodiment 1 is obtained;Swimming lane M:Albumen Marker;Swimming
Road 1:Supernatant after recombinant bacterium induction is broken;Swimming lane 2:Precipitated after recombinant bacterium induction is broken;
Fig. 6 causes cell to recombinate sheep long-acting interferon in embodiment 5 as made from the fusion protein in embodiment 1 to VSV
The inhibitory action of lesion;1 is VSV virus control wells;2 be HEp-2 cell control wells;A3-12 is gradient dilution (from right to left)
Human interferon standard items processing hole;B3-12 handles hole for the restructuring sheep long-acting interferon of gradient dilution (from right to left);
Fig. 7 is the restructuring sheep long-acting interferon intramuscular injection blood medicine as made from the fusion protein in embodiment 1 in embodiment 8
Concentration-time change curve.
Embodiment
Embodiment 1
A kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2, its preparation method is such as
Under:
1. the acquisition of sheep albumin (Alb), sheep interferon gamma (IFN-γ) and sheep interleukin 2 (IL-2) target gene
With amplification
Design of primers:
Objective gene sequence design synthetic primer according to having been reported in Genebank is shown in Table 1, in the upstream of sheep albumin
EcoRI restriction enzyme sites and Linker sequences are introduced in primer and anti-sense primer respectively, sheep interferon gamma sense primer and under
Linker sequences are introduced respectively in trip primer, are introduced respectively in the sense primer and anti-sense primer of sheep interleukin 2
Linker sequences and XhoI restriction enzyme sites.
The pcr amplification primer thing of table 1
RT-PCR obtains target gene:
RNA is extracted from sheep liver tissue, sheep Alb, sheep IFN-γ and sheep IL-2 target gene are obtained by reverse transcription,
The gene order of three is respectively such as the > and SEQUENCE of 400 < of SEQUENCE LISTING 400 <, 4 >, SEQUENCE LISTING 5
Shown in the > of 400 < of LISTING 6;
RT-PCR reaction systems (25 μ L) are shown in Table 2
The RT-PCR reaction systems of table 2
RNase Free water | 10μL |
dNTP Mix | 10μL |
Reverse transcriptase | 2.5μL |
Upstream and downstream primer | Each 0.5 μ L |
Geneome RNA | 1.5μL |
Response parameter is:50 DEG C of reverse transcriptions 30min, 95 DEG C of pre-degeneration 4min, into circulation:95 DEG C of denaturation 45s;58 DEG C are moved back
Fiery 45s, 72 DEG C of extension 1kb/min, totally 35 circulations;Last 72 DEG C of extensions 10min.
There is specific band through agarose gel electrophoresis in 1850bp, 560bp and 490bp or so in RT-PCR amplified productions,
Its result is as shown in figure 1, explanation has prepared sheep Alb, sheep IFN-γ and sheep IL-2 target gene.
2. the connection of target gene
Target gene is diluted to 10ug/mL, each section of target gene is connected using over-lap PCR, 25 μ L reaction systems are such as
Shown in table 3, table 4:
The rAlb-IFN γ PCR reaction systems of table 3
RAlb-IFN γ-IL2PCR the reaction systems of table 4
Response parameter is:95 DEG C of pre-degeneration 4min, into circulation:94 DEG C of denaturation 45s;58 DEG C of annealing 45s, 72 DEG C of extensions
1kb/min, totally 35 circulations;Last 72 DEG C of extensions 10min.
There is specific band through agarose gel electrophoresis in 2840bp or so in pcr amplification product, its result as shown in Fig. 2
RAlb-IFN γ and IL-2 amplified production bands are occurred in that in Fig. 2, because connected in rAlb-IFN γ and IL-2 gene
During, occur in that non-specific responding.The nucleotide sequence of the obtained target gene such as > institutes of 400 < of SEQUENCE LISTING 2
Show.
3. expression vector establishment
Selection connection after target gene through be sequenced it is errorless after, PCR glue reclaims product is used with pET-32a plasmids
EcoRI and XhoI restriction enzymes carry out double digestion and recovery, and double digestion is done by 20 μ L systems in table 5:
The double digestion system of table 5
General buffer | 2μL |
Restriction enzyme (a pair) | 1μL+1μL |
Carrier reclaims fragment | 2ul |
RNase Free water | 14μL |
The digestion recovery product of target gene after connection and pET-32a plasmids is attached by the system in table 6,4
DEG C overnight connect:
The enzyme disjunctor system of table 6
Purpose fragment DNA | 10μL |
Expression vector | 3μL |
buffer | 2μL |
Ligase | 1μL |
RNase Free water | 4μL |
Connection product is converted into e. coli bl21 (DE3) competent cell, competent cell is coated on benzyl containing ammonia
The LB culture medium flat plate incubated overnights of penicillin;Single bacterium colony on picking LB flat boards carries out target gene PCR identifications, positive colony
Bacteria plasmid is identified through EcoRI and XhoI double digestions, is accredited as positive and is represented that engineering bacteria is successfully constructed, PCR amplifications and double digestion
Product detects single band through agarose gel electrophoresis at 2840bp or so places, and its result is as shown in Figure 3.
4. the expression of recombinant protein
Picking engineering bacteria 37 DEG C of shaking table recovery 1h in the LB culture mediums containing 100 μ g/ml ampicillins, engineering bacteria is designated as
pET-32a/rAlb-IFNγ-IL2;The amplification culture 4h (OD ≈ 1.0) in LB culture mediums (the μ g/ml containing ampicillin 100),
Add final concentration 100 μ g/ml IPTG, 32 DEG C of induced expression 5h;Thalline is collected, through SDS-PAGE electrophoresis detections, its result is as schemed
Shown in 4, it can be seen that after bacterial cell disruption after recombinant bacterium induction 5h supernatant to be deposited in 122.6KD or so places visible
Predominant expression band, illustrates in precipitation and supernatant equal successful expression fusion protein.
Add mass volume ratio 1:Precipitation is resuspended in 1 PBS;- 20 DEG C precipitate 3 times in room temperature multigelation;4 DEG C of ultrasonic degradations
Bacterial precipitation, worked 10s, is spaced 3S, and ultrasonic 6min, whole process is repeated 3~4 times;4 DEG C, 12000r/min centrifugation 15min,
Supernatant, precipitation are taken respectively, obtain rough fusion protein.
5. fusion protein purification
5.1His affinity chromatography
After membrane filtration of the rough fusion protein with 0.22 μm of aperture, loading is by being connected to AKTA explorer 100
On protein purification system, the His affinity columns balanced with Binding Buffer I (PBS) are washed away not with PBS
With reference to albumen, until A280nm is stable, then with Elution buffer I (50mM trishydroxymethylaminomethanes, 20~500mM
Imidazoles, PH8.0) elution, collect rAlb-IFN γ-IL2 protein peaks.
5.2DEAE anion-exchange chromatography
(the 50mM trihydroxy methyls of Binding Buffer II are arrived into the albumen collected after His affinitive layer purifications displacement
Aminomethane, PH6.5) in after, the DEAE anion exchange chromatography that loading has been balanced by using Binding Buffer II,
Crossed again with Binding Buffer II after post to A280nm value stabilizations, with (the 50mM trihydroxy methyl ammonia of Elution Buffer II
Methylmethane, 1M NaCl, PH6.5) linear gradient elution, collect rAlb-IFN γ-IL2 protein peaks.
5.3 sieve chromatography
Loading is by using (the 50mM of Binding Buffer III after the sample concentration that ion-exchange chromatography is collected into
Na2HPO4,0.15M NaCl, PH7.4) molecular sieve chromatographies of Superdex 200 have been balanced, washed with Binding Buffer III
It is de-, collect rAlb-IFN γ-IL2 protein peaks.
5.4 sample identification
Determine rAlb-IFN γ-IL2 potency and specific activity, specific activity >=106IU/mg, albumen is qualified;It is aseptic subpackaged, -80
DEG C preserve.It can obtain the fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2, its amino acid sequence
Row are as shown in the > of 400 < of SEQUENCE LISTING 1.
Embodiment 2
A kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2, other be the same as Examples 1,
Simply e. coli bl21 therein (DE3) competent cell is replaced for BL21 (DE3) competence with pGro7 plasmids
Cell.The SDS-PAGE electrophoresis results be the same as Example 1 of its fusion protein is compareed, 122.6KD or so places predominant expression in supernatant
Band is thicker, illustrates to introduce after molecular chaperones pGro7, expression of the destination protein in supernatant is more preferable, obtained fusion protein
Amount is higher.The albumen of Bacillus coli expression is mostly present in inclusion body;By introducing molecular chaperones in expression bacterial strain, assist
Correctly folded with expressing protein, reach solubility expression of protein.
Described BL21 (DE3) competent cell with pGro7 plasmids is purchased from Shanghai Jinan Technology Co., Ltd./glad hundred promise
Biology, article No. V205.
Embodiment 3
A kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2, its preparation method is such as
Under:
1. the acquisition of sheep albumin (Alb), sheep interferon gamma (IFN-γ) and sheep interleukin 2 (IL-2) target gene
With amplification
Sheep Alb in embodiment 1, sheep IFN-γ and sheep IL-2 are optimized, artificial synthesized sheep Alb, sheep IFN-γ and
Sheep IL-2 target gene, after optimization, the nucleotide sequence of three is respectively such as 400 < of SEQUENCE LISTING 7 >, SEQUENCE
Shown in the > of 400 < of LISTING 400 <, 8 > and SEQUENCE LISTING 9.
1.1 codon optimization
Genetic codon has 64 kinds, but most biological tendencies are in utilizing the part in these codons.Those
By the most frequent referred to as optimal codon (optimal codons) utilized, what those were not frequently utilized that is referred to as rare or utilizes
The low codon of rate (rare or low-usage codons).In fact, conventional do protein expression or every kind of biology of production
(including Escherichia coli, yeast, mammalian cell, plant cell and insect cell) all shows codon profit to a certain degree
Difference or preference.In Escherichia coli, yeast and drosophila to the expression efficiency of the gene containing optimal codon apparently higher than containing
The expression efficiency of the gene of the codon of poor efficiency.Therefore, in heterologous expression system, the preferences of codon are largely
On have impact on the expression of recombinant protein.Using preference codon (preferred codons) and avoid utilize rare codon
Gene chemical synthesis is carried out, the redesign of this gene is codon optimization.Therefore, in the present embodiment to sheep Alb, sheep IFN-γ and
Sheep IL-2 gene codons are optimized.
Interpretation of result after 1.2 codon optimizations
It is considered as the gene during usual codon adaptation indexI (CAI)=1.0 optimal efficient in the expression system
Expression status, CAI values are lower to show that expression is lower in host.In gene G/C content most ideal distribution scope be 30~
70%, the scope is exceeded in any region can influence to translate and transcriptional efficiency.Sheep Alb, sheep are found using software detection
The codon of IFN-γ and sheep IL-2 original genes codon adaptation indexI (CAI) in Escherichia coli is respectively 0.23,0.25,
0.27, GC percentage is 44.0%, 40.9%, 54.0%;And by after to sheep Alb, sheep IFN-γ and sheep IL-2 gene optimizations
Obtain recombination codon adaptation indexI (CAI) in Escherichia coli be respectively 0.99,1.0,1.0, GC percentages 50.1%,
44.1%th, 53.0%.The utilization rate of low codon is significantly reduced by gene optimization, it is to avoid rare codon is to albumen table
The influence reached, improves the G/C content of gene, improves transcription and translation efficiency.
1.3 design of primers:
The pcr amplification primer thing of table 7
Sheep Alb after optimization, sheep IFN-γ and sheep IL-2 genomic DNA are diluted to 0.05mg/mL respectively.Utilize
PCR amplifications obtain target gene, and 25 μ L reaction systems are as shown in table 8:
The PCR reaction systems of table 8
RNase Free water | 10.5μL |
dNTP Mix | 10.0μL |
Taq archaeal dna polymerases | 2.5μL |
Upstream and downstream primer | Each 0.5 μ L |
Genomic DNA | 1.0μL |
Response parameter is:95 DEG C of pre-degeneration 4min, into circulation:95 DEG C of denaturation 45s;60 DEG C of annealing 45s, 72 DEG C of extensions
1kb/min, totally 35 circulations;Last 72 DEG C of extensions 10min.
Sheep Alb, sheep IFN-γ and sheep IL-2 pcr amplification product are through agarose gel electrophoresis respectively in 1850bp, 560bp
There is specific band with 490bp or so, illustrate to have prepared sheep Alb after optimization, sheep IFN-γ and sheep IL-2 purpose base
Cause.
2. the connection of target gene
Target gene is diluted to 10ug/mL, each section of target gene is connected using over-lap PCR, 25 μ L reaction systems are such as
Shown in table 9, table 10:
The rAlb-IFN γ PCR reaction systems of table 9
RAlb-IFN γ-IL2PCR the reaction systems of table 10
Response parameter is:95 DEG C of pre-degeneration 4min, into circulation:94 DEG C of denaturation 45s;60 DEG C of annealing 45s, 72 DEG C of extensions
1kb/min, totally 35 circulations;Last 72 DEG C of extensions 10min.
There is specific band through agarose gel electrophoresis in 2840bp or so in pcr amplification product, its result as shown in figure 5,
RAlb-IFN γ and IL-2 amplified production bands are occurred in that in Fig. 5, because connected in rAlb-IFN γ and IL-2 gene
During, occur in that non-specific responding.The nucleotide sequence of the obtained target gene such as > institutes of 400 < of SEQUENCE LISTING 3
Show.
3. expression vector establishment
The PCR errorless after sequencing of the target gene after connection glue reclaim product is selected to be used with pET-32a plasmids
EcoRI, XhoI restriction enzyme carry out double digestion and recovery, and double digestion is done by 20 μ L systems in table 11:
The double digestion system of table 11
General buffer | 2μL |
Restriction enzyme (a pair) | 1μL+1μL |
Carrier reclaims fragment | 2ul |
RNase Free water | 14μL |
The digestion recovery product of target gene after connection and pET-32a plasmids is attached by the system in table 12,4
DEG C overnight connect:
Table 12
Purpose fragment DNA | 10μL |
Expression vector | 3μL |
buffer | 2μL |
Ligase | 1μL |
RNase Free water | 4μL |
Connection product is converted into e. coli bl21 (DE3) competent cell, competence is coated on the mould of benzyl containing ammonia
Incubated overnight in the LB flat boards of element;The bacterium colony grown on LB flat boards is taken to identify target gene, positive colony bacteria plasmid warp through PCR
EcoRI, XhoI double digestion are identified, are accredited as positive and are represented expression vector establishment success, PCR amplifications and double digestion product are through fine jade
There is single band at 2840bp or so places in sepharose electrophoresis, illustrates that the expression containing rAlb-IFN γ-IL2 fusions is carried
Body is successfully constructed.
4. the expression of recombinant protein
Picking engineering bacteria 37 DEG C of shaking table recovery 1h in the LB culture mediums containing 100 μ g/ml ampicillins, engineering bacteria is designated as
pET-32a/rAlb-IFNγ-IL2;The amplification culture 4h (OD ≈ 1.0) in LB culture mediums (the μ g/ml containing ampicillin 100),
Add final concentration 100 μ g/ml IPTG, 32 DEG C of induced expression 5h;Thalline is collected, through SDS-PAGE electrophoresis detections, recombinant bacterium induction
Supernatant is deposited in the visible predominant expression band in 122.6KD or so places after bacterial cell disruption after 5h, illustrates in supernatant is precipitated
Recombinant protein is obtained.
Add mass volume ratio 1:Precipitation is resuspended in 1 PBS;- 20 DEG C precipitate 3 times in room temperature multigelation;4 DEG C of ultrasonic degradations
Bacterial precipitation, worked 10s, is spaced 3S, and ultrasonic 6min, whole process is repeated 3~4 times;4 DEG C, 12000r/min centrifugation 15min,
Supernatant, precipitation are taken respectively, obtain rough fusion protein.
5. fusion protein purification
5.1His affinity chromatography
After membrane filtration of the rough fusion protein with 0.22 μm of aperture, loading is by being connected to AKTA explorer 100
On protein purification system, the His affinity columns balanced with Binding Buffer I (PBS) are washed away not with PBS
With reference to albumen, until A280nm is stable, then with Elution buffer I (50mM trishydroxymethylaminomethanes, 20~500mM
Imidazoles, PH8.0) elution, collect rAlb-IFN γ-IL2 protein peaks.
5.2DEAE anion-exchange chromatography
(the 50mM trihydroxy methyls of Binding Buffer II are arrived into the albumen collected after His affinitive layer purifications displacement
Aminomethane, PH6.5) in after, the DEAE anion exchange chromatography that loading has been balanced by using Binding Buffer II,
Crossed again with Binding Buffer II after post to A280nm value stabilizations, with (the 50mM trihydroxy methyl ammonia of Elution Buffer II
Methylmethane, 1M NaCl, PH6.5) linear gradient elution, collect rAlb-IFN γ-IL2 protein peaks.
5.3 sieve chromatography
Loading is by using Binding Buffer III after the sample concentration that ion-exchange chromatography is collected into
(50mMNa2HPO4,0.15M NaCl, PH7.4) molecular sieve chromatographies of Superdex 200 have been balanced, use Binding Buffer
III elution, collects rAlb-IFN γ-IL2 protein peaks.
5.4 sample identification
Determine rAlb-IFN γ-IL2 potency and specific activity, specific activity >=106IU/mg, albumen is qualified;It is aseptic subpackaged ,-
80 DEG C of preservations.It can obtain the fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2, its amino acid
Sequence is as shown in the > of 400 < of SEQUENCE LISTING 1.
Embodiment 4
A kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2, other be the same as Examples 3,
Simply e. coli bl21 therein (DE3) competent cell is replaced for BL21 (DE3) competence with pGro7 plasmids
Cell.The SDS-PAGE electrophoresis results be the same as Example 3 of its fusion protein is compareed, 122.6KD or so places predominant expression in supernatant
Band is thicker, illustrates to introduce after molecular chaperones pGro7, expression of the destination protein in supernatant is more preferable, obtained fusion protein
Amount is higher.The albumen of Bacillus coli expression is mostly present in inclusion body;By introducing molecular chaperones in expression bacterial strain, assist
Correctly folded with expressing protein, reach solubility expression of protein.
Described BL21 (DE3) competent cell with pGro7 plasmids is purchased from Shanghai Jinan Technology Co., Ltd./glad hundred promise
Biology, article No. V205.
Embodiment 5
One kind restructuring sheep long-acting interferon, by the fusion protein in embodiment 1,2,3,4 respectively with freeze drying protectant mixture
Afterwards, it is freeze-dried to form.The freeze drying protectant is glycerine, mannitol and sucrose, is buffer solution with 10mmol/L PBS,
Final concentration of glycerine 100mL/L, mannitol 0.12g/mL and the sucrose 0.025g/mL of three.
Embodiment 6
Embodiment 1~4 obtains the mirror for the fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2
It is fixed
6.1 the quantitative detection of protein content
Lowry methods are used, the standard protein for examining and determine institute with Chinese food pharmaceutical biological product makees standard test, determine embodiment
1~4 obtained fusion protein concentration is all higher than 1.1mg/ml.
6.2SDS-PAGE electrophoresis detection
Compared with empty bacterium, fusion protein has the newly-increased protein band of a dense dye in 122.6KD or so, as shown in Figure 4.
6.3Western Blot results
Fusion protein in embodiment 1~4 is detected respectively, with the anti-sheep interferon (1 of abcam companies mouse:5000 dilutions) be
Primary antibody, using goat anti-mouse IgG-HRP as secondary antibody (1:10000 dilutions).Restructuring sheep long-acting interferon sample can be disturbed with anti-sheep
Specific reaction occurs for plain γ monoclonal antibodies, and specific band occur in 122.6KD or so places, as shown in Figure 5.
Embodiment 7
Four parts in embodiment 5 recombinate the freeze-dried bioactivity of sheep long-acting interferon
Suppress method according to few cells lesion, Hep-2 cells are made into 5 × 10 with culture medium5Cell/ml cells suspend
Liquid, per hole, inoculation 0.1ml moves into 96 porocyte culture plates.37 DEG C, 5%CO224h is cultivated, the restructuring sheep length of various dose is added
Imitate to inhale after interferon, 24h and abandon, then inoculation 100TCID50VSV viruses respectively.
Result of the test
As a result show that the restructuring sheep long-acting interferon obtained causes the lesion of HEp-2 cells to have obvious suppression to VSV
Effect.The lesion such as occurs cell rounding after undressed cell virus inoculation, comes off, is disintegrated.And the restructuring sheep length obtained
Imitate after the cell virus inoculation after interferon processing, the Continuous Observation under inverted microscope, cellular morphology is normal, does not occur any
Lesion, measures potency >=106IU/ml, as shown in Figure 6.
Embodiment 8
Four parts obtained respectively by the fusion protein of embodiment 1~4 restructuring sheep long-acting interferons in embodiment 5 are freeze-dried
The measure of the half-life period of (being designated as A, B, C, D respectively) in sheep body
Cytopathic-effect inhibition assay determines rAlb-IFN γ-IL2 blood concentration and time relationship
The sheep (male and female half and half) that six body weight are roughly the same is taken, 2mg/ml restructuring sheep long-acting interferons α is subcutaneously injected in neck
Freeze-dried 2ml, respectively in 1h, 3h, 6h, 12h, 24h, 36h, 48h, 72h venous blood collection, 4 DEG C of solidifications of blood sample, 3500rpm low temperature
10min separation serum is centrifuged, each every sheep blood sample of time point is to be measured in -20 DEG C of preservations.Serum is determined using cytopathic-effect inhibition assay
RAlb-IFN γ-IL2 concentration in sample, is carried out curve fitting and calculating parameter with DAS pharmacokinetics softwares.Parameter result of calculation
It is shown in Table 13.
Dominant dynamic parameters in serum after the restructuring sheep long-acting interferon intramuscular injection of table 13
As a result show that restructuring sheep long-acting interferon has longer half-life period.Half-life period can reach 70h or so after measured, more general
Logical interferon improves about 17 times.
Embodiment 9
Four parts of freeze-dried measure influenceed on sheep cellullar immunologic response of restructuring sheep long-acting interferon in embodiment 5
Take six roughly the same mutton sheeps of body weight to be divided into two groups, be designated as experimental group and control group;Experimental group neck is subcutaneously noted
The 2mg/ml restructuring freeze-dried 2ml of sheep long-acting interferon are penetrated, 2mL PBS is subcutaneously injected in control group neck, takes after injecting 4 weeks outside sheep
All blood, takes weekly a blood afterwards, and lymphocyte is separated using lymphocyte separation medium, and lymphocyte passes through serum-free RPMI
1640 culture mediums are washed after 2 times, and it is 2 × 10 to be resuspended with complete medium, adjust cell concentration6Individual/ml, 24 porocyte culture plates are every
Hole adds 1ml lymphocytes, 37 DEG C, 5%CO272h is cultivated, supernatant when collecting lymphocyte culture.ELISA detects culture supernatant
Middle IL-4 contents, are carried out, testing result is as shown in table 14 by kit specification:
The ELISA of table 14 detects each group sheep cellullar immunologic response level
As a result show after injection restructuring sheep long-acting interferon, containing for sheep Evaluation of Cytokines in Peripheral Blood IL-4 can be significantly improved
Amount, enhances cellullar immunologic response level, significantly improves immunity level.
It is above-mentioned with reference to embodiment to a kind of fusion egg being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2
The detailed description that bletilla its preparation method is carried out, is illustrative rather than limited, can be included according to limited scope
Several embodiments, therefore changing and modifications in the case where not departing from present general inventive concept, should belong to protection scope of the present invention it
It is interior.
SEQUENCE LISTING
<110>Wuhu Co., Ltd of Ying Tefeier biological products industrial research institute
<120>A kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2 and its preparation side
Method
<130> 1
<160> 9
<170> PatentIn version 3.3
<210> 1
<211> 948
<212> PRT
<213>Fusion protein
<400> 1
Met Lys Trp Val Thr Phe Ile Ser Leu Leu Leu Leu Phe Ser Ser Ala
1 5 10 15
Tyr Ser Arg Gly Val Phe Arg Arg Asp Thr His Lys Ser Glu Ile Ala
20 25 30
His Arg Phe Lys Asp Leu Gly Glu Glu His Phe Lys Gly Leu Val Leu
35 40 45
Ile Ala Phe Ser Gln Tyr Leu Gln Gln Cys Pro Phe Asp Glu His Val
50 55 60
Lys Leu Val Asn Glu Leu Thr Glu Phe Ala Lys Thr Cys Val Ala Asp
65 70 75 80
Glu Ser His Ala Gly Cys Glu Lys Ser Leu His Thr Leu Phe Gly Asp
85 90 95
Glu Leu Cys Lys Val Ala Ser Leu Arg Glu Thr Tyr Gly Asp Met Ala
100 105 110
Asp Cys Cys Glu Lys Gln Glu Pro Glu Arg Asn Glu Cys Phe Leu Ser
115 120 125
His Lys Asp Asp Ser Pro Asp Leu Pro Lys Leu Lys Pro Asp Pro Asn
130 135 140
Thr Leu Cys Asp Glu Phe Lys Ala Asp Glu Lys Lys Phe Trp Gly Lys
145 150 155 160
Tyr Leu Tyr Glu Ile Ala Arg Arg His Pro Tyr Phe Tyr Ala Pro Glu
165 170 175
Leu Leu Tyr Tyr Ala Asn Lys Tyr Asn Gly Val Phe Gln Glu Cys Cys
180 185 190
Gln Ala Glu Asp Lys Gly Ala Cys Leu Leu Pro Lys Ile Glu Thr Met
195 200 205
Arg Glu Lys Val Leu Ala Ser Ser Ala Arg Gln Arg Leu Arg Cys Ala
210 215 220
Ser Ile Gln Lys Phe Gly Glu Arg Ala Leu Lys Ala Trp Ser Val Ala
225 230 235 240
Arg Leu Ser Gln Lys Phe Pro Lys Ala Glu Phe Val Glu Val Thr Lys
245 250 255
Leu Val Thr Asp Leu Thr Lys Val His Lys Glu Cys Cys His Gly Asp
260 265 270
Leu Leu Glu Cys Ala Asp Asp Arg Ala Asp Leu Ala Lys Tyr Ile Cys
275 280 285
Asp Asn Gln Asp Thr Ile Ser Ser Lys Leu Lys Glu Cys Cys Asp Lys
290 295 300
Pro Leu Leu Glu Lys Ser His Cys Ile Ala Glu Val Glu Lys Asp Ala
305 310 315 320
Ile Pro Glu Asn Leu Pro Pro Leu Thr Ala Asp Phe Ala Glu Asp Lys
325 330 335
Asp Val Cys Lys Asn Tyr Gln Glu Ala Lys Asp Ala Phe Leu Gly Ser
340 345 350
Phe Leu Tyr Glu Tyr Ser Arg Arg His Pro Glu Tyr Ala Val Ser Val
355 360 365
Leu Leu Arg Leu Ala Lys Glu Tyr Glu Ala Thr Leu Glu Glu Cys Cys
370 375 380
Ala Lys Asp Asp Pro His Ala Cys Tyr Ser Thr Val Phe Asp Lys Leu
385 390 395 400
Lys His Leu Val Asp Glu Pro Gln Asn Leu Ile Lys Gln Asn Cys Asp
405 410 415
Gln Phe Glu Lys Leu Gly Glu Tyr Gly Phe Gln Asn Ala Leu Ile Val
420 425 430
Arg Tyr Thr Arg Lys Val Pro Gln Val Ser Thr Pro Thr Leu Val Glu
435 440 445
Val Ser Arg Ser Leu Gly Lys Val Gly Thr Arg Cys Cys Thr Lys Pro
450 455 460
Glu Ser Glu Arg Met Pro Cys Thr Glu Asp Tyr Leu Ser Leu Ile Leu
465 470 475 480
Asn Arg Leu Cys Val Leu His Glu Lys Thr Pro Val Ser Glu Lys Val
485 490 495
Thr Lys Cys Cys Thr Glu Ser Leu Val Asn Arg Arg Pro Cys Phe Ser
500 505 510
Ala Leu Thr Pro Asp Glu Thr Tyr Val Pro Lys Ala Phe Asp Glu Lys
515 520 525
Leu Phe Thr Phe His Ala Asp Ile Cys Thr Leu Pro Asp Thr Glu Lys
530 535 540
Gln Ile Lys Lys Gln Thr Ala Leu Val Glu Leu Leu Lys His Lys Pro
545 550 555 560
Lys Ala Thr Glu Glu Gln Leu Lys Thr Val Met Glu Asn Phe Val Ala
565 570 575
Phe Val Asp Lys Cys Cys Ala Ala Asp Asp Lys Glu Ala Cys Phe Ala
580 585 590
Val Glu Gly Pro Lys Leu Val Val Ser Thr Gln Thr Ala Leu Ala Gly
595 600 605
Gly Gly Gly Ser Gly Gly Gly Gly Ser Met Lys Tyr Thr Ser Ser Phe
610 615 620
Leu Ala Leu Leu Leu Cys Val Leu Leu Gly Phe Ser Gly Ser Tyr Gly
625 630 635 640
Gln Gly Pro Phe Phe Lys Glu Ile Glu Asn Leu Lys Glu Tyr Phe Asn
645 650 655
Ala Ser Asn Pro Asp Val Ala Lys Gly Gly Pro Leu Phe Ser Glu Ile
660 665 670
Leu Lys Asn Trp Lys Glu Glu Ser Asp Lys Lys Ile Ile Gln Ser Gln
675 680 685
Ile Val Ser Phe Tyr Phe Lys Leu Phe Glu Asn Leu Lys Asp Asn Gln
690 695 700
Val Ile Gln Arg Ser Met Asp Ile Ile Lys Gln Asp Met Phe Gln Lys
705 710 715 720
Phe Leu Asn Gly Ser Ser Glu Lys Leu Glu Asp Phe Lys Arg Leu Ile
725 730 735
Gln Ile Pro Val Asp Asp Leu Gln Ile Gln Arg Lys Ala Ile Asn Glu
740 745 750
Leu Ile Lys Val Met Asn Asp Leu Ser Pro Lys Ser Asn Leu Arg Lys
755 760 765
Arg Lys Arg Ser Gln Asn Leu Phe Arg Gly Arg Arg Ala Ser Met Gly
770 775 780
Gly Gly Gly Ser Gly Gly Gly Gly Ser Met Tyr Lys Ile Gln Pro Leu
785 790 795 800
Ser Cys Ile Ala Leu Thr Leu Ala Leu Val Ala Asn Gly Ala Pro Thr
805 810 815
Ser Ser Ser Thr Gly Asn Thr Met Lys Glu Val Lys Ser Leu Leu Leu
820 825 830
Asp Leu Gln Leu Leu Leu Glu Lys Val Lys Asn Pro Glu Asn Leu Lys
835 840 845
Leu Ser Arg Met His Thr Phe Asn Phe Tyr Met Pro Lys Val Asn Ala
850 855 860
Thr Glu Leu Lys His Leu Lys Cys Leu Leu Glu Glu Leu Lys Leu Leu
865 870 875 880
Glu Glu Val Leu Asp Leu Ala Pro Ser Lys Asn Leu Asn Thr Arg Glu
885 890 895
Ile Lys Asp Ser Met Asp Asn Ile Lys Arg Ile Val Leu Glu Leu Gln
900 905 910
Gly Ser Glu Thr Arg Phe Thr Cys Glu Tyr Asp Asp Ala Thr Val Lys
915 920 925
Ala Val Glu Phe Leu Asn Lys Trp Ile Thr Phe Cys Gln Ser Ile Tyr
930 935 940
Ser Thr Met Thr
945
<210> 2
<211> 2844
<212> DNA
<213>Genome 1
<400> 2
atgaagtggg tgacttttat ttcccttctc cttctcttca gctctgctta ttccaggggt 60
gtgtttcgtc gagatacaca caagagtgag attgctcatc ggtttaatga tttgggagaa 120
gaaaattttc aaggcctggt gctgattgcc ttttctcagt atctccagca gtgtccattt 180
gacgaacatg taaaattagt gaaggagcta actgagtttg caaaaacatg tgttgctgat 240
gagtcacatg ccggttgtga taagtcactt cacactctct ttggagatga attgtgtaaa 300
gttgcaaccc ttcgcgaaac ctatggtgac atggccgact gctgtgagaa acaagagcct 360
gaaagaaatg aatgcttcct gaatcacaaa gatgatagcc cagacctccc taaactgaaa 420
ccagagcccg atactttgtg tgccgagttt aaggcagatg aaaagaagtt ttggggaaaa 480
tacctatacg aagttgccag aagacatccc tacttttatg caccagaact cctttactat 540
gctaataaat ataatggagt ttttcaagaa tgctgccaag ctgaagataa aggtgcctgc 600
ctactaccaa agattgacgc tatgagagaa aaagtactgg cttcatctgc cagacagaga 660
ctcaggtgtg ccagtattca aaaattcgga gaaagagctt taaaagcatg gtcagtagct 720
cgcctgagcc agaaatttcc caaggctgac tttacagatg ttaccaagat agtgacagat 780
ctcactaagg tccacaagga gtgttgccat ggtgacctgc ttgaatgcgc agacgacagg 840
gcagatcttg ccaagtacat atgtgatcat caagacgcac tctccagtaa actgaaggaa 900
tgctgtgata agcctgtgtt ggaaaaatcc cactgcattg ctgaggtaga taaagatgcc 960
gtgcctgaaa acctgccccc attaactgct gactttgctg aagataagga ggtttgcaaa 1020
aactatcagg aagcaaaaga cgtcttcctg ggctcgtttt tgtatgaata ttcaagaagg 1080
catcctgagt atgctgtctc agtgctattg agacttgcca aggaatatga agccacactg 1140
gaggactgct gtgccaaaga agatccacat gcctgctatg ccacagtgtt tgacaaactt 1200
aagcatcttg tggatgagcc tcagaattta atcaaaaaaa actgtgagct attcgaaaaa 1260
catggagagt atggattcca aaatgcgctc atagttcgtt acaccaggaa agcaccccaa 1320
gtgtcaactc caactctggt ggagatttca agaagcctag gaaaagtggg cactaagtgt 1380
tgtgcaaagc ctgaatcaga aagaatgccc tgtaccgaag actatctgag cttgatcctg 1440
aaccggttgt gcgtgttgca tgagaagaca ccagtgagtg aaaaagtcac caagtgctgc 1500
acggagtcat tggtgaacag acggccatgt ttctctgatc tgacacttga cgaaacatat 1560
gtacccaaac ccttcgatga gaaatttttc accttccatg cagatatatg cacacttcct 1620
gatactgaga aacaaatcaa gaaacaaact gcacttgttg agctgttgaa acacaagccc 1680
aaggcaacag atgaacaact gaaaaccgtt atggagaatt ttgtggcttt tgtagacaag 1740
tgctgtgcag ctgatgacaa agaaggctgc tttgttctgg agggtccaaa acttgttgct 1800
tcaactcaag cagccttagc cggtggtggt ggttctggtg gtggtggttc tatgaaatac 1860
acaagctcct tcttagcttt actgctctgt gtgcttttgg gtttttctgg ttcttatggc 1920
cagggcccat tttttaaaga aatagaaaac ttaaaggagt attttaatgc aagtaaccca 1980
gatgtagcta agggtgggcc tcttttctca gaaattttga agaattggaa agaggagagt 2040
gacaaaaaga ttattcagag ccaaattgtc tccttctact tcaaactctt tgaaaacctc 2100
aaagataacc aggtcattca aaggagcatg gatatcatca agcaagacat gtttcagaag 2160
ttcttgaacg gcagctctga gaaactggag gacttcaaaa ggctgattca aattccggtg 2220
gatgatctgc agatccagcg caaagccatc aatgaactca tcaaggtgat gaatgacctg 2280
tcgccaaaat ctaacctcag aaagcggaag agaagtcaga atctctttcg aggccggaga 2340
gcatcaatgg gtggtggtgg ttctggtggt ggtggttcta tgtacaagat acaacccttg 2400
tcttgcattg cactaactct tgcactcgtt gcaaacggtg cacctacttc aagctctacg 2460
gggaacacaa tgaaagaagt gaagtcattg ctgctagatt tacagttgct tttggagaaa 2520
gttaaaaatc ccgagaacct caagctctcc aggatgcata catttaactt ctacatgccc 2580
aaggttaacg ctacagaatt gaaacatctt aagtgtttac tagaagaact caaacttcta 2640
gaggaagtgc tagatttagc tccaagcaaa aacctgaaca ccagagagat caaggattca 2700
atggacaata tcaagagaat agttttggaa ctacagggat ctgaaacaag attcacatgt 2760
gaatatgatg atgcgacagt aaaggctgta gaatttctga acaaatggat taccttttgt 2820
caaagcatct actcaacaat gact 2844
<210> 3
<211> 2844
<212> DNA
<213>Genome 2
<400> 3
atgaaatggg ttaccttcat ctctctgctg ctgctgttct cttctgctta ctctcgtggt 60
gttttccgtc gtgacaccca caaatctgaa atcgctcacc gtttcaaaga cctgggtgaa 120
gaacacttca aaggtctggt tctgatcgct ttctctcagt acctgcagca gtgcccgttc 180
gacgaacacg ttaaactggt taacgaactg accgaattcg ctaaaacctg cgttgctgac 240
gaatctcacg ctggttgcga aaaatctctg cacaccctgt tcggtgacga actgtgcaaa 300
gttgcttctc tgcgtgaaac ctacggtgac atggctgact gctgcgaaaa acaggaaccg 360
gaacgtaacg aatgcttcct gtctcacaaa gacgactctc cggacctgcc gaaactgaaa 420
ccggacccga acaccctgtg cgacgaattc aaagctgacg aaaaaaaatt ctggggtaaa 480
tacctgtacg aaatcgctcg tcgtcacccg tacttctacg ctccggaact gctgtactac 540
gctaacaaat acaacggtgt tttccaggaa tgctgccagg ctgaagacaa aggtgcttgc 600
ctgctgccga aaatcgaaac catgcgtgaa aaagttctgg cttcttctgc tcgtcagcgt 660
ctgcgttgcg cttctatcca gaaattcggt gaacgtgctc tgaaagcttg gtctgttgct 720
cgtctgtctc agaaattccc gaaagctgaa ttcgttgaag ttaccaaact ggttaccgac 780
ctgaccaaag ttcacaaaga atgctgccac ggtgacctgc tggaatgcgc tgacgaccgt 840
gctgacctgg ctaaatacat ctgcgacaac caggacacca tctcttctaa actgaaagaa 900
tgctgcgaca aaccgctgct ggaaaaatct cactgcatcg ctgaagttga aaaagacgct 960
atcccggaaa acctgccgcc gctgaccgct gacttcgctg aagacaaaga cgtttgcaaa 1020
aactaccagg aagctaaaga cgcttttctc ggtagcttcc tgtacgaata ctctcgtcgt 1080
cacccggaat acgctgtttc tgttctgctg cgtctggcta aagaatacga agctaccctg 1140
gaagaatgct gcgctaaaga cgacccgcac gcttgctact ctaccgtttt cgacaaactg 1200
aaacacctgg ttgacgaacc gcagaacctg atcaaacaga actgcgacca gttcgaaaaa 1260
ctgggtgaat acggtttcca gaacgctctg atcgttcgtt acacccgtaa agttccgcag 1320
gtttctaccc cgaccctggt tgaagtttct cgttctctgg gtaaagttgg tacccgttgc 1380
tgcaccaaac cggaatctga acgtatgccg tgcaccgaag actacctgtc tctgatcctg 1440
aaccgtctgt gcgttctgca cgaaaaaacc ccggtttctg aaaaagttac caaatgctgc 1500
accgaatctc tggttaaccg tcgtccgtgc ttctctgctc tgaccccgga cgaaacctac 1560
gttccgaaag ctttcgacga aaaactgttc accttccacg ctgacatctg caccctgccg 1620
gacaccgaaa aacagatcaa aaaacagacc gctctggttg aactgctgaa acacaaaccg 1680
aaagctaccg aagaacagct gaaaaccgtt atggaaaact tcgttgcttt cgttgacaaa 1740
tgctgcgctg ctgacgacaa agaagcttgc ttcgctgttg aaggtccgaa actggttgtt 1800
tctacccaga ccgctctggc tggtggtggt ggttctggtg gtggtggttc tatgaaatac 1860
acctcttctt tcctggctct gctgctgtgc gttctgctgg gtttctctgg ttcttacggt 1920
cagggtccgt tcttcaaaga aatcgaaaac ctgaaagaat acttcaacgc ttctaacccg 1980
gacgttgcta aaggtggtcc gctgttctct gaaatcctga aaaactggaa agaagaatct 2040
gacaaaaaaa tcatccagtc tcagatcgtt tctttctact tcaaactgtt cgaaaacctg 2100
aaagacaacc aggttatcca gcgttctatg gacatcatca aacaggacat gttccagaaa 2160
ttcctgaacg gttcttctga aaaactggaa gacttcaaac gtctgatcca gatcccggtt 2220
gacgacctgc agatccagcg taaagctatc aacgaactga tcaaagttat gaacgacctg 2280
tctccgaaat ctaacctgcg taaacgtaaa cgttctcaga acctgttccg tggtcgtcgt 2340
gcttctatgg gtggtggtgg ttctggtggt ggtggttcta tgtacaaaat ccagccgctg 2400
tcttgcatcg ctctgaccct ggctctggtt gctaacggtg ctccgacctc ttcttctacc 2460
ggtaacacca tgaaagaagt taaatctctg ctgctggacc tgcagctgct gctggaaaaa 2520
gttaaaaacc cggaaaacct gaaactgtct cgtatgcaca ccttcaactt ctacatgccg 2580
aaagttaacg ctaccgaact gaaacacctg aaatgcctgc tggaagaact gaaactgctg 2640
gaagaagttc tggacctggc tccgtctaaa aacctgaaca cccgtgaaat caaagactct 2700
atggacaaca tcaaacgtat cgttctggaa ctgcagggtt cggagaccag gttcacctgc 2760
gaatacgacg acgctaccgt taaagctgtt gaattcctga acaaatggat caccttctgc 2820
cagtctatct actctaccat gacc 2844
<210> 4
<211> 1821
<212> DNA
<213>Sheep albumin
<400> 4
atgaagtggg tgacttttat ttcccttctc cttctcttca gctctgctta ttccaggggt 60
gtgtttcgtc gagatacaca caagagtgag attgctcatc ggtttaatga tttgggagaa 120
gaaaattttc aaggcctggt gctgattgcc ttttctcagt atctccagca gtgtccattt 180
gacgaacatg taaaattagt gaaggagcta actgagtttg caaaaacatg tgttgctgat 240
gagtcacatg ccggttgtga taagtcactt cacactctct ttggagatga attgtgtaaa 300
gttgcaaccc ttcgcgaaac ctatggtgac atggccgact gctgtgagaa acaagagcct 360
gaaagaaatg aatgcttcct gaatcacaaa gatgatagcc cagacctccc taaactgaaa 420
ccagagcccg atactttgtg tgccgagttt aaggcagatg aaaagaagtt ttggggaaaa 480
tacctatacg aagttgccag aagacatccc tacttttatg caccagaact cctttactat 540
gctaataaat ataatggagt ttttcaagaa tgctgccaag ctgaagataa aggtgcctgc 600
ctactaccaa agattgacgc tatgagagaa aaagtactgg cttcatctgc cagacagaga 660
ctcaggtgtg ccagtattca aaaattcgga gaaagagctt taaaagcatg gtcagtagct 720
cgcctgagcc agaaatttcc caaggctgac tttacagatg ttaccaagat agtgacagat 780
ctcactaagg tccacaagga gtgttgccat ggtgacctgc ttgaatgcgc agacgacagg 840
gcagatcttg ccaagtacat atgtgatcat caagacgcac tctccagtaa actgaaggaa 900
tgctgtgata agcctgtgtt ggaaaaatcc cactgcattg ctgaggtaga taaagatgcc 960
gtgcctgaaa acctgccccc attaactgct gactttgctg aagataagga ggtttgcaaa 1020
aactatcagg aagcaaaaga cgtcttcctg ggctcgtttt tgtatgaata ttcaagaagg 1080
catcctgagt atgctgtctc agtgctattg agacttgcca aggaatatga agccacactg 1140
gaggactgct gtgccaaaga agatccacat gcctgctatg ccacagtgtt tgacaaactt 1200
aagcatcttg tggatgagcc tcagaattta atcaaaaaaa actgtgagct attcgaaaaa 1260
catggagagt atggattcca aaatgcgctc atagttcgtt acaccaggaa agcaccccaa 1320
gtgtcaactc caactctggt ggagatttca agaagcctag gaaaagtggg cactaagtgt 1380
tgtgcaaagc ctgaatcaga aagaatgccc tgtaccgaag actatctgag cttgatcctg 1440
aaccggttgt gcgtgttgca tgagaagaca ccagtgagtg aaaaagtcac caagtgctgc 1500
acggagtcat tggtgaacag acggccatgt ttctctgatc tgacacttga cgaaacatat 1560
gtacccaaac ccttcgatga gaaatttttc accttccatg cagatatatg cacacttcct 1620
gatactgaga aacaaatcaa gaaacaaact gcacttgttg agctgttgaa acacaagccc 1680
aaggcaacag atgaacaact gaaaaccgtt atggagaatt ttgtggcttt tgtagacaag 1740
tgctgtgcag ctgatgacaa agaaggctgc tttgttctgg agggtccaaa acttgttgct 1800
tcaactcaag cagccttagc c 1821
<210> 5
<211> 498
<212> DNA
<213>Sheep IFN-γ
<400> 5
atgaaataca caagctcctt cttagcttta ctgctctgtg tgcttttggg tttttctggt 60
tcttatggcc agggcccatt ttttaaagaa atagaaaact taaaggagta ttttaatgca 120
agtaacccag atgtagctaa gggtgggcct cttttctcag aaattttgaa gaattggaaa 180
gaggagagtg acaaaaagat tattcagagc caaattgtct ccttctactt caaactcttt 240
gaaaacctca aagataacca ggtcattcaa aggagcatgg atatcatcaa gcaagacatg 300
tttcagaagt tcttgaacgg cagctctgag aaactggagg acttcaaaag gctgattcaa 360
attccggtgg atgatctgca gatccagcgc aaagccatca atgaactcat caaggtgatg 420
aatgacctgt cgccaaaatc taacctcaga aagcggaaga gaagtcagaa tctctttcga 480
ggccggagag catcaatg 498
<210> 6
<211> 465
<212> DNA
<213>Sheep IL-2
<400> 6
atgtacaaga tacaaccctt gtcttgcatt gcactaactc ttgcactcgt tgcaaacggt 60
gcacctactt caagctctac ggggaacaca atgaaagaag tgaagtcatt gctgctagat 120
ttacagttgc ttttggagaa agttaaaaat cccgagaacc tcaagctctc caggatgcat 180
acatttaact tctacatgcc caaggttaac gctacagaat tgaaacatct taagtgttta 240
ctagaagaac tcaaacttct agaggaagtg ctagatttag ctccaagcaa aaacctgaac 300
accagagaga tcaaggattc aatggacaat atcaagagaa tagttttgga actacaggga 360
tctgaaacaa gattcacatg tgaatatgat gatgcgacag taaaggctgt agaatttctg 420
aacaaatgga ttaccttttg tcaaagcatc tactcaacaa tgact 465
<210> 7
<211> 1821
<212> DNA
<213>Sheep albumin
<400> 7
atgaaatggg ttaccttcat ctctctgctg ctgctgttct cttctgctta ctctcgtggt 60
gttttccgtc gtgacaccca caaatctgaa atcgctcacc gtttcaaaga cctgggtgaa 120
gaacacttca aaggtctggt tctgatcgct ttctctcagt acctgcagca gtgcccgttc 180
gacgaacacg ttaaactggt taacgaactg accgaattcg ctaaaacctg cgttgctgac 240
gaatctcacg ctggttgcga aaaatctctg cacaccctgt tcggtgacga actgtgcaaa 300
gttgcttctc tgcgtgaaac ctacggtgac atggctgact gctgcgaaaa acaggaaccg 360
gaacgtaacg aatgcttcct gtctcacaaa gacgactctc cggacctgcc gaaactgaaa 420
ccggacccga acaccctgtg cgacgaattc aaagctgacg aaaaaaaatt ctggggtaaa 480
tacctgtacg aaatcgctcg tcgtcacccg tacttctacg ctccggaact gctgtactac 540
gctaacaaat acaacggtgt tttccaggaa tgctgccagg ctgaagacaa aggtgcttgc 600
ctgctgccga aaatcgaaac catgcgtgaa aaagttctgg cttcttctgc tcgtcagcgt 660
ctgcgttgcg cttctatcca gaaattcggt gaacgtgctc tgaaagcttg gtctgttgct 720
cgtctgtctc agaaattccc gaaagctgaa ttcgttgaag ttaccaaact ggttaccgac 780
ctgaccaaag ttcacaaaga atgctgccac ggtgacctgc tggaatgcgc tgacgaccgt 840
gctgacctgg ctaaatacat ctgcgacaac caggacacca tctcttctaa actgaaagaa 900
tgctgcgaca aaccgctgct ggaaaaatct cactgcatcg ctgaagttga aaaagacgct 960
atcccggaaa acctgccgcc gctgaccgct gacttcgctg aagacaaaga cgtttgcaaa 1020
aactaccagg aagctaaaga cgcttttctc ggtagcttcc tgtacgaata ctctcgtcgt 1080
cacccggaat acgctgtttc tgttctgctg cgtctggcta aagaatacga agctaccctg 1140
gaagaatgct gcgctaaaga cgacccgcac gcttgctact ctaccgtttt cgacaaactg 1200
aaacacctgg ttgacgaacc gcagaacctg atcaaacaga actgcgacca gttcgaaaaa 1260
ctgggtgaat acggtttcca gaacgctctg atcgttcgtt acacccgtaa agttccgcag 1320
gtttctaccc cgaccctggt tgaagtttct cgttctctgg gtaaagttgg tacccgttgc 1380
tgcaccaaac cggaatctga acgtatgccg tgcaccgaag actacctgtc tctgatcctg 1440
aaccgtctgt gcgttctgca cgaaaaaacc ccggtttctg aaaaagttac caaatgctgc 1500
accgaatctc tggttaaccg tcgtccgtgc ttctctgctc tgaccccgga cgaaacctac 1560
gttccgaaag ctttcgacga aaaactgttc accttccacg ctgacatctg caccctgccg 1620
gacaccgaaa aacagatcaa aaaacagacc gctctggttg aactgctgaa acacaaaccg 1680
aaagctaccg aagaacagct gaaaaccgtt atggaaaact tcgttgcttt cgttgacaaa 1740
tgctgcgctg ctgacgacaa agaagcttgc ttcgctgttg aaggtccgaa actggttgtt 1800
tctacccaga ccgctctggc t 1821
<210> 8
<211> 498
<212> DNA
<213>Sheep IFN-γ
<400> 8
atgaaataca cctcttcttt cctggctctg ctgctgtgcg ttctgctggg tttctctggt 60
tcttacggtc agggtccgtt cttcaaagaa atcgaaaacc tgaaagaata cttcaacgct 120
tctaacccgg acgttgctaa aggtggtccg ctgttctctg aaatcctgaa aaactggaaa 180
gaagaatctg acaaaaaaat catccagtct cagatcgttt ctttctactt caaactgttc 240
gaaaacctga aagacaacca ggttatccag cgttctatgg acatcatcaa acaggacatg 300
ttccagaaat tcctgaacgg ttcttctgaa aaactggaag acttcaaacg tctgatccag 360
atcccggttg acgacctgca gatccagcgt aaagctatca acgaactgat caaagttatg 420
aacgacctgt ctccgaaatc taacctgcgt aaacgtaaac gttctcagaa cctgttccgt 480
ggtcgtcgtg cttctatg 498
<210> 9
<211> 465
<212> DNA
<213>Sheep IL-2
<400> 9
atgtacaaaa tccagccgct gtcttgcatc gctctgaccc tggctctggt tgctaacggt 60
gctccgacct cttcttctac cggtaacacc atgaaagaag ttaaatctct gctgctggac 120
ctgcagctgc tgctggaaaa agttaaaaac ccggaaaacc tgaaactgtc tcgtatgcac 180
accttcaact tctacatgcc gaaagttaac gctaccgaac tgaaacacct gaaatgcctg 240
ctggaagaac tgaaactgct ggaagaagtt ctggacctgg ctccgtctaa aaacctgaac 300
acccgtgaaa tcaaagactc tatggacaac atcaaacgta tcgttctgga actgcagggt 360
tcggagacca ggttcacctg cgaatacgac gacgctaccg ttaaagctgt tgaattcctg 420
aacaaatgga tcaccttctg ccagtctatc tactctacca tgacc 465
Claims (10)
1. a kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2, it is characterised in that:It is described
The amino acid sequence table of fusion protein is designated as fusion protein 1 as shown in the > of 400 < of SEQUENCE LISTING 1;Or such as
Shown in the > of 400 < of SEQUENCE LISTING 2, fusion protein 2 is designated as.
2. a kind of gene for encoding fusion protein as claimed in claim 1, it is characterised in that the nucleotide sequence of the gene
Table is designated as genome 1 as shown in the > of 400 < of SEQUENCE LISTING 3;Or as shown in the > of 400 < of SEQUENCE LISTING 4,
It is designated as genome 2.
3. the expression vector containing gene as claimed in claim 2.
4. the genetic engineering bacterium containing gene as claimed in claim 2.
5. one kind restructuring sheep long-acting interferon, it is characterised in that the restructuring sheep long-acting interferon is as melting described in claim 1
It is freeze-dried to form after hop protein and freeze drying protectant mixture.
6. the preparation method of fusion protein according to claim 1, it is characterised in that the preparation method includes following step
Suddenly:Expression vector described in claim 3 is imported into e. coli host cell, genetic engineering bacterium, genetic engineering is obtained
Bacterium obtains the crude product of the fusion protein after IPTG induced expressions, purified to can obtain fusion protein afterwards.
7. preparation method according to claim 6, it is characterised in that the genetic engineering bacterium is pET-32a/rAlb-IFN
γ, its preparation method is:
(1) primer is designed, is obtained by reverse transcription or is manually respectively synthesized the sheep albumin for connecting flexible linker sequences, sheep
The target gene of interferon gamma, sheep interleukin 2;By flexible linker by sheep albumin, sheep interferon gamma, sheep leucocyte
The target gene of interleukin 2 is connected, the nucleotides sequence list such as SEQUENCE LISTING 400 of the target gene after connection
Shown in the > of < 3 or as shown in the > of 400 < of SEQUENCE LISTING 4;
(2) target gene after connection is connected on pET-32a plasmids and obtains expression vector;
(3) expression vector is imported into e. coli host cell, you can obtain genetic engineering bacterium pET-32a/rAlb-IFN
γ-IL2。
8. the preparation method according to claim 6 or 7, it is characterised in that the e. coli host cell is BL21
(DE3) competent cell or BL21 (DE3) competent cell with pGro7 plasmids.
9. the preparation method according to claim 6 or 7, it is characterised in that the method for the purifying is:Fusion protein it is thick
Purified after product elder generation through affinity chromatography, anion-exchange chromatography and sieve chromatography.
10. the application of restructuring sheep long-acting interferon according to claim 5, it is characterised in that the restructuring sheep is long-acting dry
The long half time of element is disturbed up to more than 70 hours, with broad-spectrum disease resistance toxic action and the immune response of sheep itself can be improved.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710676689.3A CN107245109A (en) | 2017-08-09 | 2017-08-09 | A kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2 and preparation method thereof |
CN201810750980.5A CN108840944A (en) | 2017-08-09 | 2018-07-10 | A kind of fusion protein and preparation method thereof being made of sheep albumin, sheep interferon gamma and sheep interleukin 2 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710676689.3A CN107245109A (en) | 2017-08-09 | 2017-08-09 | A kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2 and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107245109A true CN107245109A (en) | 2017-10-13 |
Family
ID=60013109
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710676689.3A Pending CN107245109A (en) | 2017-08-09 | 2017-08-09 | A kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2 and preparation method thereof |
CN201810750980.5A Withdrawn CN108840944A (en) | 2017-08-09 | 2018-07-10 | A kind of fusion protein and preparation method thereof being made of sheep albumin, sheep interferon gamma and sheep interleukin 2 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810750980.5A Withdrawn CN108840944A (en) | 2017-08-09 | 2018-07-10 | A kind of fusion protein and preparation method thereof being made of sheep albumin, sheep interferon gamma and sheep interleukin 2 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN107245109A (en) |
-
2017
- 2017-08-09 CN CN201710676689.3A patent/CN107245109A/en active Pending
-
2018
- 2018-07-10 CN CN201810750980.5A patent/CN108840944A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CN108840944A (en) | 2018-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108840947A (en) | Bovine albumin-interferon-' alpha '-interleukin-22 fusion protein, preparation method and its encoding gene, a kind of ox long-acting interferon | |
CN108794638A (en) | A kind of recombinant bovine long-acting interferon α and the fusion protein and preparation method thereof for preparing this long-acting interferon | |
CN107286254A (en) | Dog albumin interferon-' alpha ' interleukin-22 fusion protein, preparation method and its encoding gene, a kind of dog long-acting interferon | |
CN107286255A (en) | It is a kind of by OVA, chicken interferon gamma and chicken interferon α fusion protein constituted and preparation method thereof | |
CN108822220A (en) | Sheep albumin-interferon-tau-interleukin-22 fusion protein, preparation method and its encoding gene, a kind of sheep long-acting interferon | |
CN107353347A (en) | A kind of fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha and preparation method thereof | |
CN107383205A (en) | Pig albumin interferon-' alpha ' interleukin-22 fusion protein, preparation method and its encoding gene, a boar long-acting interferon | |
CN108794644A (en) | A kind of fusion protein and preparation method thereof being made of cattle interleukins-2 2, Bov IFN γ and Bov IFN α | |
CN108840941A (en) | A kind of fusion protein and preparation method thereof for recombinating sheep long-acting interferon γ and preparing this long-acting interferon γ | |
CN107254000A (en) | A kind of fusion protein being made up of sheep albumin and sheep interferon gamma and preparation method thereof and a kind of restructuring sheep long-acting interferon γ | |
CN108840953A (en) | A kind of fusion protein and preparation method thereof being made of sheep interleukin 2, sheep interferon gamma and sheep interferon-tau | |
CN108822221A (en) | A kind of fusion protein and preparation method thereof being made of Chicken Albumin, chicken interferon gamma and recombinant chIL-2 | |
CN107253994A (en) | A kind of fusion protein being made up of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha and preparation method thereof | |
CN107245110A (en) | A kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interferon-tau and preparation method thereof | |
CN107365390A (en) | A kind of fusion protein being made up of pig albumin, Porcine interferon-gamma and pig interleukin 2 and 6 and preparation method thereof | |
CN107353348A (en) | A kind of restructuring sheep long-acting interferon τ and prepare fusion protein of this long-acting interferon and preparation method thereof | |
CN107253995A (en) | It is a kind of by bovine albumin, Bov IFN γ and Bov IFN α fusion protein constituted and preparation method thereof | |
CN107253997A (en) | A kind of recombinant bovine long-acting interferon and prepare fusion protein of this long-acting interferon and preparation method thereof | |
CN107245109A (en) | A kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2 and preparation method thereof | |
CN107266588A (en) | A kind of fusion protein being made up of bovine albumin, Bov IFN γ and cattle interleukins-2 2 and preparation method thereof | |
CN107266589A (en) | A kind of fusion protein being made up of dog albumin, dog interferon γ and canine leucocyte interleukin 2 and preparation method thereof | |
CN108864306A (en) | A kind of fusion protein and preparation method thereof being made of canine leucocyte interleukin 2, dog interferon γ and dog interferon alpha | |
CN108864299A (en) | A kind of canine recombinant long-acting interferon γ and the fusion protein and preparation method thereof for preparing this long-acting interferon γ | |
CN107266586A (en) | A kind of Recombinant Swine long-acting interferon γ and prepare this long-acting interferon γ fusion protein and preparation method thereof | |
CN109053897A (en) | A kind of fusion protein and preparation method thereof being made of recombinant chIL-2, chicken interferon gamma and chicken interferon α |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20171013 |
|
WD01 | Invention patent application deemed withdrawn after publication |